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BioenergeticsModulation of mitochondrial free Ca2+ ([Ca2+]m) is implicated as one of the possible upstream factors that
initiates anesthetic-mediated cardioprotection against ischemia–reperfusion (IR) injury. To unravel possible
mechanismsbywhich volatile anestheticsmodulate [Ca2+]m andmitochondrial bioenergetics,with implications
for cardioprotection, experimentswere conducted to spectroﬂuorometricallymeasure concentration-dependent
effects of isoﬂurane (0.5, 1, 1.5, 2 mM) on themagnitudes and time-courses of [Ca2+]m andmitochondrial redox
state (NADH), membrane potential (ΔΨm), respiration, and matrix volume. Isolated mitochondria from rat
hearts were energized with 10 mMNa+- or K+-pyruvate/malate (NaPM or KPM) or Na+-succinate (NaSuc) fol-
lowed by additions of isoﬂurane, 0.5 mM CaCl2 (≈200 nM free Ca2+with 1 mM EGTA buffer), and 250 μMADP.
Isoﬂurane stepwise: (a) increased [Ca2+]m in state 2 with NaPM, but not with KPM substrate, despite an
isoﬂurane-induced slight fall in ΔΨm and a mild matrix expansion, and (b) decreased NADH oxidation, respira-
tion, ΔΨm, and matrix volume in state 3, while prolonging the duration of state 3 NADH oxidation, respiration,
ΔΨm, and matrix contraction with PM substrates. These ﬁndings suggest that isoﬂurane's effects are mediated
in part at the mitochondrial level: (1) to enhance the net rate of state 2 Ca2+ uptake by inhibiting the Na+/
Ca2+ exchanger (NCE), independent of changes in ΔΨm and matrix volume, and (2) to decrease the rates of
state 3 electron transfer and ADP phosphorylation by inhibiting complex I. These direct effects of isoﬂurane to
increase [Ca2+]m, while depressing NCE activity and oxidative phosphorylation, could underlie the mechanisms
by which isoﬂurane provides cardioprotection against IR injury at the mitochondrial level.
© 2011 Elsevier B.V. All rights reserved.1. Introduction
Ischemia–reperfusion (IR) injury results in mitochondrial dys-
function, as shown by impaired mitochondrial ATP production and
dysregulation of mitochondrial Ca2+ homeostasis, resulting from re-
duced membrane potential (ΔΨm), increased matrix swelling, release
of cytochrome c, and eventual cell membrane rupture and death
[1–4]. An increase in cytosolic free Ca2+ ([Ca2+]c), with a subsequent
increase in mitochondrial free Ca2+ ([Ca2+]m), is believed to be a
major contributor of mitochondrial dysfunction and mitochondria-
mediated cardiac cell injury or death during IR injury [4–6].Experimental Biology Meeting
ting (Biophys J 100:81a, 2011).
gineering Center, Medical Col-
aukee, WI 53226-6509, USA.
rights reserved.Therefore, the use of drugs or cytoprotective strategies that interfere
with cytosolic Ca2+ homeostasis could serve as an important strategy
in cardioprotection by delaying the onset of IR injury [3,7,8].
Anesthetic pre- and post-conditioning (APC and APOC) have
emerged as powerful strategies in cardioprotection against IR injury
[2,8–10]. A better understanding of the mechanisms of anesthetics
to modify cardiac cell function may provide guidance on how to re-
duce or delay cardiac cell injury caused by IR. Cardiac mitochondria
are believed to play an essential role in mediating cardioprotection
by anesthetics [2,8,11,12]. Modulation of [Ca2+]m is believed to be
one of the upstream factors that initiates a cascade of protective ki-
nases during cardiac APC or APOC against IR injury [2,4–7,13]. In
view of the increasingly recognized role of mitochondria as initiators
and effectors of various cardioprotective signaling pathways, the ef-
fect of isoﬂurane (a volatile anesthetic) to alter mitochondrial Ca2+
handling and bioenergetics could provide novel insights into the
mechanisms by which anesthetics mediate cardioprotection against
IR injury.
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mode of Ca2+ entry into respiring mitochondria [14]; the Ca2+
entry is dependent on [Ca2+]c, ΔΨm, and interference by other diva-
lent cations (e.g., Mg2+) that impede Ca2+ entry [15–17]. On the
other hand, Na+/Ca2+ exchanger (NCE) serves as a principal Ca2+ ef-
ﬂux pathway for maintaining mitochondrial Ca2+ homeostasis during
physiological and pathological conditions. Ca2+ is an integral compo-
nent of the signaling pathways involved in anesthetic-mediated cardio-
protection [2,4,6,13]. However, how volatile anesthetics (e.g.,
isoﬂurane) modulate the CU or other Ca2+ transporters (e.g., NCE) to
alter mitochondrial Ca2+ transients and bioenergetics that inﬂuence
cellular function, and how these effects relate to cardioprotection, have
not been explored.
The aim of this study was to investigate the direct effects of iso-
ﬂurane on mitochondrial Ca2+ uptake and release and associated
changes in bioenergetics that together, or singly, may underlie the
mechanisms of volatile anesthetic-mediated cardioprotection. Our
hypothesis was that isoﬂurane modulates [Ca2+]m, by modulating
the CU or NCE, in a ΔΨm- and matrix volume-independent manner,
while also altering the bioenergetic state. To test this hypothesis, we
used freshly isolated rat heart mitochondria energized with various
substrates (Na+- or K+-pyruvate/malate (NaPM or KPM) or Na+-
succinate (NaSuc)) and used ﬂuorescence techniques to investigate
how extra-matrix additions of 0.5 mM CaCl2 ([Ca2+]e≈200 nM
with 1 mM EGTA buffer) and 250 μM ADP alter [Ca2+]m, NADH
redox state, respiration, ΔΨm, and matrix volume with several con-
centrations of isoﬂurane (0, 0.5, 1, 1.5, 2 mM). We found that isoﬂur-
ane has a concentration-dependent effect to increase state 2 [Ca2+]m
with NaPM, but not with KPM substrate, and to increase matrix vol-
ume and decrease ΔΨm with all substrates, while depressing mito-
chondrial bioenergetics, i.e., decreasing state 3 NADH oxidation,
respiration, ΔΨm, and matrix volume. These results indicate that iso-
ﬂurane's effects are mediated in part at the mitochondrial level to en-
hance the net rate of state 2 Ca2+ uptake by attenuating the activity
of NCE, independent of ΔΨm and matrix volume, and to inhibit com-
plex I to decrease the rate and prolong the duration of state 3 electron
transport and ADP phosphorylation.2. Materials and methods
2.1. Mitochondrial isolation
The Medical College of Wisconsin Institutional Animal Care and
Use Committee (IACUC) approved the animal use and the experimen-
tal protocols of this study. Rat heart mitochondria were isolated by
differential centrifugation methods, as described previously for guin-
ea pig hearts [18–20], with some minor modiﬁcations. Hearts were
isolated fromWistar rats (300–350 g), anesthetizedwith sodium thiobu-
tabarbital (Inactin, Sigma-Aldrich, St. Louis, MO; 150 mg/kg intraperito-
neally), and were minced in ice-cold “isolation buffer” containing (in
mM) 200 mannitol, 50 sucrose, 5 KH2PO4, 5 3-(N-morpholino) propane-
sulfonic acid (MOPS), and1 EGTA,with 0.1% bovine serumalbumin (BSA)
at pH 7.15 (adjusted with KOH). The minced hearts were suspended in
2.5 ml isolation buffer with 5U/ml protease and homogenized for 30 s.
Next, 15 ml isolation buffer was added and the suspension was homoge-
nized further for 60 s. The suspension volumewas then adjusted to 25 ml
and centrifuged at 8000 g for 10 min. The supernatant was discarded and
the pellet was resuspended in 25 ml isolation buffer and centrifuged at
700 g for 10 min. Next, the pellet was discarded and the supernatant
was centrifuged at 700 g for 10 min. The supernatant from this step
was centrifuged again at 8000 g for 10 min to yield theﬁnalmitochondri-
al pellet, which was suspended in 0.5 ml isolation buffer and kept on ice
until used. All isolation procedureswere carried out in a cold room (4 °C).
The mitochondrial protein content was determined using BSA as the
standard with Biorad Quick Start Bradford Assay Kit [21]. Depending onthe protein content, the suspension volume was adjusted to have a pro-
tein concentration of 5 mg protein/ml isolation buffer.
2.2. Indo-1 and DMSO loading
For [Ca2+]mmeasurements,mitochondria (5 mg protein/ml isolation
buffer) were incubated in 5 μM indo-1 AM for 20 min at 25 °C with con-
stant stirring [18]. Next, the suspension volume was adjusted to 25 ml
and recentrifuged at 8000 g for 10 min to remove the residual dye. The
dye-loaded mitochondrial pellet was resuspended in 0.5 ml isolation
buffer and kept on ice until used. Mitochondrial protein content was
redetermined and the suspension volume was readjusted as described
above. For bioenergetic measurements (respiration, NADH, ΔΨm, and
matrix volume), mitochondria were loaded with DMSO (vehicle for
indo-1 AM; 0.1% ﬁnal concentration) to mimic the experimental condi-
tions of indo-1 loaded mitochondria. All experiments were conducted
at room temperature (25 °C), unless otherwise stated.
2.3. Mitochondrial O2 consumption measurement
To test the functional integrity of mitochondria in day to day ex-
periments and also to examine the effect of isoﬂurane on states 2, 3
and 4 respiration, the rates of mitochondrial O2 consumption were
measured polarographically [18–20] at 30 °C with a Clark type elec-
trode system (System S 200A; Strathkelvin Instruments, Glasgow,
UK). The DMSO or dye loaded mitochondria were suspended in “res-
piration buffer” (0.5 mg protein/ml) containing (in mM) 130 KCl, 5
K2HPO4, 20 MOPS, 1 EGTA, and 0.1% BSA at pH 7.15 adjusted with
KOH. State 2 respiration was initiated with complex I substrate
Na+-pyruvate/ malate (NaPM; 10 mM) in the presence of DMSO (ve-
hicle) or different concentrations of isoﬂurane (0.5, 1, 1.5, 2 mM)
given prior to substrate addition. State 3 respiration was measured
by adding 250 μM ADP and state 4 respiration was measured after
phosphorylation of ADP to ATP. The time-line protocol for the respira-
tion experiments is shown in Fig. 1A. To test the functional integrity
of mitochondria on a given experimental day, the respiratory control
index (RCI) was calculated from the respiration rate ratio of state 3/
state 2 or state 3/state 4. Mitochondrial preparations from hearts
with DMSO or dye incubation consistently provided RCIs of about 6
(state 3/state 2) and 4 (state 3/state 4). These mitochondria provided
consistent data on bioenergetics (respiration, NADH, ΔΨm, and ma-
trix volume) and [Ca2+]m in day to day experiments.
2.4. Mitochondrial redox state (NADH) measurement
The DMSO loaded mitochondria at a concentration of 0.5 mg pro-
tein/ml respiration buffer were used to spectrophotometrically (PTI:
Photon Technology International, Birmingham, NJ) measure the
time-courses of NADH during states 2, 3 and 4 respiration in the pres-
ence of DMSO (vehicle) or isoﬂurane (0.5, 1, 1.5, 2 mM), given after
attaining state 2 respiration with NaPM, followed by 0.5 mM CaCl2
(≈200 nM free Ca2+) and 250 μM ADP. The time-courses of NADH
during states 2, 3 and 4 respiration were also assessed to compare ef-
fects of complex I substrate (NaPM) and complex II substrate (NaSuc)
in the presence of DMSO, isoﬂurane (1 mM) or rotenone (30 nM),
with and without 0.5 mM added CaCl2; 30 nM rotenone was used to
mimic the response of 1 mM isoﬂurane.
The time-line protocol for the NADH measurements is shown in
Fig. 1B. NADH was measured as autoﬂuorescence [18,19] by exciting
the mitochondrial sample at 350 nm (λex) and collecting the emission
signals (F) at 456 nm and 395 nm (λem). The λem's were switched be-
tween two photon counters with a time resolution of 1 s. The F395 sig-
nals were less sensitive to the NADH changes, but account for light
scattering associated with matrix volume changes and/or conforma-
tional changes, which were proportionally present in the F456 signals
that are sensitive to the NADH changes. Therefore, the ﬂuorescence
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Fig. 1. Time-line protocols (in s) for isolated mitochondrial experiments. (A) Respiration experiments, (B) [Ca2+]m, NADH, ΔΨm and matrix volume experiments, and (C) Extended
time-line protocol for [Ca2+]m measurements involving NCE kinetics. Mito: mitochondria; PM: pyruvate/malate; DMSO: dimethyl sulfoxide; Iso: isoﬂurane; CaCl2: calcium chlo-
ride; ADP: adenosine diphosphate; FCCP: carbonyl cyanide p-triﬂuoromethoxyphenylhydrazone; CCCP: carbonylcyanide m-chlorophenylhydrazone; Rot: rotenone; NCE: Na+/
Ca2+ exchanger.
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corrects for artifacts due to changes in the light scattering. Rotenone
(1 μM) and FCCP (20 μM) were added in state 4 to obtain the end
points for calibration of the NADH time-course between maximally
reduced and maximally oxidized states. The NADH autoﬂuorescence
signals at the two respective wavelengths were also used as back-
ground ﬂuorescence signals for analyzing the indo-1 AM ﬂuorescence
signals for [Ca2+]m measurements.2.5. Mitochondrial free Ca2+ ([Ca2+]m) measurement
The indo-1 loaded mitochondria (0.5 mg protein/ml respiration
buffer) were used in the same cuvette system (PTI) to spectrophoto-
metrically measure the time-courses of [Ca2+]m during states 2, 3 and
4 respiration in the absence and presence of isoﬂurane (0, 0.5, 1, 1.5,
2 mM), with the same time-line protocol as described for NADH
(Fig. 1B). In another set of experiments, the time-line protocol for
[Ca2+]m measurements was extended (Fig. 1C) to evaluate the effects
of 1 mM isoﬂurane on both Ca2+ uptake via the CU and Ca2+ efﬂux
via the NCE, using the substrate KPM or NaPM with CGP-37157 (an
inhibitor of NCE) present. Fluorescence signals with the DMSO (for
background autoﬂuorescence, NADH) or indo-1 (for [Ca2+]m) loaded
mitochondria were obtained at the same excitation (λex=350 nm)
and emission (λem=395 and 456 nm) wavelengths. The signals
from the respective mitochondria were subtracted, time point by
time point, to correct for the effect of background autoﬂuorescence
(NADH) on indo-1 ﬂuorescence. The ratio of the two corrected signals
(R=F395/F456) accounted for individual signal variations as well as
for the differences in the amount of indo-1 taken up into the matrix
in a given experiment. The Rmax signal (maximum Ca2+ load that
leads to saturation of indo-1 dye with Ca2+) was determined by add-
ing 0.5 μM cyclosporine A (CsA, mPTP: mitochondrial permeability
transition pore blocker) and 5 mM CaCl2 to the respiring mitochon-
dria; the Rmin signal (zero Ca2+ load where all indo-1 dye become
free of Ca2+) was monitored with A23187 (a Ca2+ ionophore) that
was added to the mitochondria during state 2 respiration [18].
[Ca2+]m was calculated using the standard calibration formula
[22]: [Ca2+]m (nM)=Kd,app·Sf2/Sb2·(R–Rmin) / (Rmax–R); Kd,app
(apparent dissociation constant for dye-Ca2+ binding) was deter-
mined to be 330 nM at pH 7.15; Sf2 is the signal intensity of free
indo-1 measured at 456 nm and Sb2 is the signal intensity of Ca2+-sat-
urated indo-1measured at 456 nm. The ratio Sf2/Sb2, Rmax, and Rminwas
measured independently for each day's experiments.For [Ca2+]m calibration, the measured Kd,app (330 nM)was further
corrected to account for pH changes that occur due to release of pro-
tons from 1 mM EGTA present in the buffer with addition of
0.5 mM CaCl2. This correction was made using the formula Kd,
app=Kd (1+[H+] /KH), where KH is the dissociation constant for
binding of protons to indo-1, which is about 10−6.5 M or 315 nM, and
Kd is the true dissociation constant for binding of Ca2+ to indo-1,
which is about 265 nM. Matrix pH was measured spectroﬂuorometri-
cally in the same PTI system using 2′7′-bis-(2-carboxyethyl)-5′(and
6-) carboxy-ﬂuorescein (BCECF) AM loaded mitochondria that leads
to a pH decrease of 0.07 units (data not shown) upon addition of
0.5 mM CaCl2 to 1 mM EGTA buffer. Accounting for this pH change,
the Kd,app increases from 330 nM to 344 nM.
Althoughmatrix indo-1 ﬂuorescencewasmeasured during states 2, 3
and 4 respiration, we show here only the [Ca2+]m time-course during
state 2 respiration. In a recent study [18], we observed that matrix
indo-1 ﬂuorescence increases when ADP is added to the buffer, and
that ﬂuorescence returns to the baseline (state 2) level after ADP is phos-
phorylated to ATP; this results in an apparent increase in [Ca2+]m during
state 3 respiration [18]. However, the mechanism of this increase in ma-
trix indo-1 ﬂuorescence, leading to the apparent increase in [Ca2+]m,
during state 3 respiration is unclear. Therefore, we do not have an accu-
rate measure of [Ca2+]m after ADP addition (states 3 and 4).
2.6. Mitochondrial membrane potential (ΔΨm) measurement
ΔΨm was measured during states 2, 3 and 4 respiration in the same
PTI system using the ﬂuorescent dye rhodamine 123 (Rh123; 50 nM;
Calbiochem, San Diego, CA) in the buffer with λex=503 nm and
λem=527 nm [23]. Rh123 is a monovalent cation that is taken up into
the matrix of charged mitochondria where it accumulates due to a
large electronegative potential. An increase in ΔΨm is associated with
a decrease in ﬂuorescence intensity. The DMSO loaded mitochondria
were suspended in respiration buffer (0.5 mg protein/ml) and the
time-course of ΔΨm was measured under various experimental condi-
tions with the same time-line protocol as for NADH and [Ca2+]m
(Fig. 1B). The uncoupler CCCP (4 μM) was added to maximally (100%)
depolarize the mitochondria; ΔΨm at any time point was expressed as
a percentage of the ﬂuorescence with maximal depolarization.
2.7. Mitochondrial matrix volume measurement
Changes in matrix volume as a consequence of changes in the
water and solute contents of the matrix after adding substrate,
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measured spectroﬂuorometrically in the same PTI system using
light-scattering technique [24, 25]. This was carried out by exciting
the DMSO loaded mitochondrial sample (0.5 mg protein/ml) at a par-
ticular wavelength and collecting the emitted signals (photon counts)
at the same wavelength (e.g., λex=λem=520 nm). A decrease and
increase in photon counts due to light scattering is interpreted as
the expansion and contraction of matrix volume, respectively. The
light scattering signals were normalized with respect to their baseline
levels (prior to substrate addition). Because the signals at all wave-
lengths were proportionally scattered (data not shown), we corrected
the indo-1 ﬂuorescence signals for NADH autoﬂuorescence to accu-
rately estimate both NADH and [Ca2+]m.
2.8. Time-line protocols for experiments
Fig. 1A shows the time-line protocol for respiration measure-
ments, whereas Fig. 1B depicts the time-line protocol used for
NADH, [Ca2+]m, ΔΨm, and matrix volume measurements; Fig. 1C
shows the extended time-line protocol for [Ca2+]mmeasurements in-
volving NCE kinetics. In all cases, the experiments were initiated at
t=0 with isolated mitochondria suspended in the respiration buffer
(0.5 mg protein/ml). The time-course of states 2, 3 and 4 respiration
was monitored by adding to the mitochondrial sample DMSO (vehi-
cle) or isoﬂurane at t=30 s, followed by substrate (NaPM; 10 mM)
at t=60 s and ADP (250 μM) at t=120 s, which initiates state 3 res-
piration proceeding to state 4 respiration after the conversion of ADP
to ATP (Fig. 1A). On theother hand, the time-courses of NADH, [Ca2+]m,
ΔΨm, and matrix volume were measured during each respiration state
by adding the substrate (NaPM; 10 mM or NaSuc; 10 mM) at t=60 s,
followed by DMSO/isoﬂurane or rotenone (30 nM) at t=180 s, CaCl2
(0 or 0.5 mM) at t=300 s, and ADP (250 μM) at t=480 s (Fig. 1B). In
the extended time-line protocol for [Ca2+]mmeasurements for inferring
NCE kinetics (Fig. 1C), instead of ADP, the CU inhibitor ruthenium red
(RR; 25 μM) was added at t=480 s followed by the addition of NaCl
(10 mM) at t=540 s. In NADH measurements, rotenone (1 μM) or
FCCP (20 μM) was added at t=660 s (state 4) to achieve maximally re-
duced andmaximally oxidized autoﬂuorescence signals, respectively, as
the end points for NADH calibration. Similarly, in ΔΨm measurements,
CCCP (4 μM) was added at t=660 s to maximally (100%) depolarize
the mitochondria, as the end point for ΔΨm calibration. To account for
the effects of DMSO alone, experiments were conducted with a control
group (no treatment) and the data were compared to isoﬂurane and
DMSO group data.
Isoﬂurane was dissolved in DMSO to achieve concentrations of 0.5, 1,
1.5 and 2 mM that correspond to 1, 2, 3 and 4 minimal alveolar concen-
tration (MAC), respectively,which are values commonly used for surgical
anesthesia. The actual isoﬂurane concentrations at the beginning and
end of each day's experiments were veriﬁed by gas chromatography
(GC). Average concentrations of isoﬂurane by GC varied within ±10%
of their initially prepared values of 0.5, 1, 1.5 and 2 mM.
2.9. Data analysis and statistics
All data were analyzed using computer programswritten inMATLAB
that access the raw data of speciﬁc variables (NADH, [Ca2+]m,ΔΨm, and
matrix volume) from Excel® spread sheets of day to day experiments
generated from the PTI software. The programs performed the necessary
calculations to calibrate absolute values and changes in variables from
one state to the other, including statistical analyses (i.e., computations
of mean, standard deviation, and standard error of a particular variable
over multiple day experiments). The program for [Ca2+]m calcula-
tions utilized both indo-1 ﬂuorescence signals andNADH autoﬂuores-
cence signals for background and light scattering corrections. The ﬁnal
data of a particular variable were expressed as mean±standard error
(SE) over at least 4 replicates of the same variable (n=4). Comparisonswithin and between groups were performed by linear regression analy-
sis, or by one-way ANOVA (analysis of variance) with Tukey's post-hoc
test for signiﬁcance of means. Differences with Pb0.05 (two-tailed)
were considered signiﬁcant.
3. Results
3.1. Isoﬂurane-induced decreases in mitochondrial respiration
The concentration-dependent effect of isoﬂurane (0.5, 1, 1.5,
2 mM) on the time-courses of mitochondrial O2 concentration during
states 2, 3 and 4 respiration with NaPM is shown in Fig. 2A; the cor-
responding rates of respiration (O2 consumption), RCIs (state 3/
state 4 and state 3/state 2) that are measures of mitochondrial integ-
rity, and duration of state 3 respiration are summarized in Fig. 2B, C,
D. Isoﬂurane signiﬁcantly decreased state 3 respiration in a
concentration-dependent manner: 178±2.5, 159±2.3, 87±1.7 and
70±1 nmol mg−1 min−1 at 0.5, 1, 1.5 and 2 mM isoﬂurane, respective-
ly, when compared to the control (192±3) and DMSO (202±3.1)
groups, without appreciably changing state 2 or state 4 respiration
among all groups (Fig. 2B). The effects of isoﬂurane on state 3 respiration
were alsomanifested in the computed RCIs (Fig. 2C) and observed dura-
tion of state 3 respiration: 34±1 s, 41±2.1 s, 53±1.7 s and 67±2.4 s at
0.5, 1, 1.5 and 2 mM isoﬂurane, respectively, compared to the control
(27±2 s) and DMSO (29±1.7 s) groups (Fig. 2D). This slowed rate
and prolonged duration of state 3 respiration with NaPM and increasing
isoﬂurane concentration indicates a slower rate of electron transport and
ADP phosphorylation. However, the amount of O2 consumed during
state 3 respiration (ADP phosphorylation) remained approximately con-
stant, suggesting that the P/O ratio remained approximately constant,
≈2.5.
3.2. Isoﬂurane-induced changes in mitochondrial redox state (NADH)
The concentration-dependent effect of isoﬂurane and 0.5 mM
CaCl2 (≈200 nM free Ca2+) on the time-courses of mitochondrial
NADH during states 2, 3 and 4 respiration with NaPM is shown in
Fig. 3A. The corresponding % NAD+ reduced with Ca2+, % NADH oxi-
dized with ADP, and duration of state 3 NADH oxidation are summa-
rized in Fig. 3B, C, D. Isoﬂurane had little effect on NADH levels during
state 2 or state 4 respiration as shown in the time-course tracings
(Fig. 3A). Adding 0.5 mM CaCl2 caused a slight additional increase in
state 2 NADH levels (about 3%), independent of isoﬂurane concentra-
tion (Fig. 3B). Adding ADP caused a signiﬁcant oxidation of NADH in
control and DMSO groups; however, in the presence of isoﬂurane,
ADP promoted a pronounced isoﬂurane concentration-dependent de-
crease in state 3 NADH oxidation: 20±1.8, 15±2, 10±3 and 10±3%
at 0.5, 1, 1.5 and 2 mM isoﬂurane, respectively, when compared to the
control (29±3%) or DMSO (29±4%) groups (Fig. 3C). In addition, iso-
ﬂurane also signiﬁcantly increased the duration of state 3 NADH oxida-
tion: 78±8.2 s, 95±13.8 s, 104±15.3 s and 123±16 s at 0.5, 1, 1.5
and 2 mM isoﬂurane, respectively, compared to the control (63±4.2 s)
and DMSO (65±4.8 s) group (Fig. 3D). This ADP-induced decrease in
the rate and increase in the duration of NADH oxidation with NaPM
and increased isoﬂurane concentration is consistent with the depressed
state 3 respiration due, in part, to slowed rate of electron transfer and
ADP phosphorylation; this is likely attributable to complex I inhibition
by isoﬂurane.
To further evaluate that isoﬂurane inhibits complex I in our model,
the time courses of mitochondrial redox state (NADH) during states
2, 3 and 4 respiration were measured and compared with different
substrates (NaPM, Fig. 4A, B; NaSuc, Fig. 4C, D), with 0.5 mM added
CaCl2 (≈200 nM free Ca2+) vs. no added CaCl2 (Fig. 4A, C vs.
Fig. 4B, D), and with isoﬂurane (1 mM), rotenone (30 nM), and vehi-
cle (DMSO). These data show that 1 mM isoﬂurane could mimic the
inhibition of complex I by 30 nM rotenone with both substrates and
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the duration of state 3 NADH oxidation was longer with the DMSO
control than with either isoﬂurane (1 mM) or rotenone (30 nM)
due to inhibition of complex I.
3.3. Isoﬂurane-induced decreases in mitochondrial membrane potential
(ΔΨm)
The concentration-dependent effect of isoﬂurane and 0.5 mM
CaCl2 (≈200 nM free Ca2+) on the transients of ΔΨm during states
2, 3 and 4 respiration with NaPM is shown in Fig. 5A. The correspond-
ing % depolarization in ΔΨm with added isoﬂurane and ADP and du-
ration of state 3 ΔΨm depolarization are summarized in Fig. 5(B, C,
D). Isoﬂurane lowered ΔΨm during states 2, 3 and 4 respiration as
shown in the time-dependent traces (Fig. 5A). Isoﬂurane caused a
slight concentration-dependent fall in ΔΨm in state 2 up to 2.7%,
with negligible changes in control and DMSO groups (Fig. 5B); adding
0.5 mM CaCl2 did not alter ΔΨm appreciably beyond the light scatter-
ing effects due to matrix volume expansion. Addition of ADP caused a
transient and reversible phosphorylation-dependent depolarization
of mitochondria in all groups. Isoﬂurane increased the transient de-
crease in ΔΨm by ADP (Fig. 5C) in a concentration-dependent man-
ner, as well as prolonged the duration of depolarization (Fig. 5D):
from 71±5 s (control) and 71±5 s (DMSO) to 83±2 s(Iso=0.5 mM), 112±5 s (Iso=1 mM), 147±6 s (Iso=1.5 mM),
and 181±4 s (Iso=2 mM). This observation of isoﬂurane on ADP-
induced falls in ΔΨm and rise in the duration of ΔΨm depolarization
with NaPM with increasing isoﬂurane concentration is corroborated
by the decreased rate and increased duration of state 3 respiration
and NADH oxidation, which together reﬂects the effect of isoﬂurane
to slow the rates of electron transfer and ADP phosphorylation.
3.4. Isoﬂurane-induced changes in mitochondrial matrix volume
The changes in matrix volume with additions of substrate (NaPM;
10 mM), CaCl2 (0.5 mM) andADP (250 μM) in control, DMSOand isoﬂur-
ane (0.5, 1, 1.5, 2 mM) groups are shown in Fig. 6A. The corresponding %
changes in matrix volume from baselines with added CaCl2 and ADP and
duration of state 3 volume change are summarized in Fig. 6B, C, D.
Isoﬂurane and CaCl2 each caused changes in matrix volume during
states 2, 3 and 4 respiration as shown in the time-dependent traces
(Fig. 6A); in general, isoﬂurane and CaCl2 caused volume expansion,
whereas ADP caused volume contraction. Isoﬂurane induced a small
dose-dependent volume expansion in state 2 compared to the control
and DMSO groups; adding CaCl2 led to further volume expansion in
all groups (≈4–5%), nearly independent of isoﬂurane concentration
(Fig. 6B). Adding ADP caused volume contraction that was dependent
on isoﬂurane concentration (%): 6.7±0.8 (control), 6.4±1.1 (DMSO),
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(Iso=1.5 mM), and 9.9±1.3 (Iso=2mM) (Fig. 6C). Isoﬂurane in-
creased the duration of ADP-induced volume contraction from
48±0.3 s (control) and 49±0.9 s (DMSO) to 56±3 s
(Iso=0.5 mM), 68±2 s (Iso=1 mM), 86±5 s (Iso=1.5 mM), and
109±7 s (Iso=2mM) (Fig. 6D). This increase in the duration of
ADP-induced volume contraction with NaPM and increasing isoﬂurane
concentration is consistent with the increased durations of state 3 res-
piration (Fig. 2D), NADH oxidation (Fig. 3D), and ΔΨm depolarization
(Fig. 5D), each reﬂecting slower rates of electron ﬂow and ADP phos-
phorylation in the presence of isoﬂurane.
3.5. Isoﬂurane-induced changes in mitochondrial free Ca2+ ([Ca2+]m)
The concentration-dependent effect of isoﬂurane and 0.5 mM
CaCl2 (≈200 nM free Ca2+) on the dynamics of [Ca2+]m during
state 2 respiration with NaPM is shown in Fig. 7A. The corresponding
increases in state 2 [Ca2+]m with added CaCl2 are summarized in
Fig. 7B. Isoﬂurane increased [Ca2+]m in a concentration-dependent
manner after adding 0.5 mM CaCl2 as shown in the time-dependent
traces (Fig. 7A). The Na+-dependent substrate NaPM caused an initial
small decrease in [Ca2+]m from ~150 nM to almost 0 nM due to acti-
vation of the NCE (Fig. 7A). Adding 0.5 mM CaCl2 during state 2respiration caused an increase in [Ca2+]m to 707±80 nM and 702±
70 nM in the control and DMSO groups, respectively, indicating that
DMSOdid not itself alter [Ca2+]m (Fig. 7B). In the presence of isoﬂurane,
[Ca2+]m increased signiﬁcantly over the control and DMSO values in a
concentration-dependent manner to 815±80 nM (Iso=0.5 mM),
960±80 nM (Iso=1 mM), 1074±70 nM (Iso=1.5 mM), and 1158±
70 nM (Iso=2 mM) (Fig. 7B), despite the isoﬂurane-induced slight
ΔΨm depolarization (Fig. 5B) and mild matrix expansion (Fig. 6B) dur-
ing state 2 respiration.
Isoﬂurane may differentially alter the activity of themitochondri-
al CU or NCE as a cause for the increased [Ca2+]m after adding CaCl2
using NaPM substrate. To test this, [Ca2+]m was measured with KPM
vs. NaPM in the presence of a NCE inhibitor (CGP-37157) at a single
concentration of isoﬂurane (1 mM) vs. DMSO with 0.5 mM added
CaCl2 (≈200 nM free Ca2+) followed by additions of RR (25 μM)
and NaCl (10 mM) (Fig. 7C, D). These data show that isoﬂurane did
not induce any further increase in [Ca2+]m (1153±58 nM) com-
pared to DMSO (1189±66 nM) with the substrate KPM or NaPM+
CGP during the Ca2+ uptake phase (t=450 s). However, isoﬂurane
attenuated matrix Ca2+ efﬂux, as assessed by decreased [Ca2+]m, after
blocking the CU with RR and then adding NaCl in the KPM substrate ex-
periments ([Ca2+]m=848±13 nM at t=600 s and 121±34 nM at
t=900 s with DMSO vs. 987±41 nM at t=600 s and 237±57 nM at
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NaCl addition was totally negated when CGP was used with the Na+-
containing substrate (NaPM). These data thus indicate that the
isoﬂurane-mediated increases in [Ca2+]mwith theNa+-based substrate
(NaPM) is a direct result of attenuated NCE activity.
4. Discussion
The mitochondrion is recognized as an upstream target for cardiac
IR injury and a downstream effector of cardioprotection during vola-
tile anesthetic-induced pre- and post-conditioning (APC, APOC)
[2–4,6,8]. The precise mechanisms of triggering, signaling and media-
tion of the cardioprotective action of volatile anesthetics (e.g., isoﬂur-
ane) involving mitochondria remain elusive. The direct effects of
isoﬂurane on mitochondrial bioenergetics and Ca2+ homeostasis
were the focus of this study with the aim to better understand the
mechanisms underlying the cardioprotective effect of volatile
anesthetics.
We used isolated cardiac mitochondria (respiring with different sub-
strates: NaPM, KPMandNaSuc) and ﬂuorescence techniques to study the
effects of extra-matrix additions of 0.5 mM CaCl2 ([Ca2+]e≈200 nM
with1 mMEGTAbuffer) and250 μMADPon [Ca2+]m,NADH, respiration,
ΔΨm, andmatrix volume at several concentrations of isoﬂurane (0, 0.5, 1,
1.5, 2 mM). We found that isoﬂurane has several direct and interrelated
effects on mitochondrial function. Foremost, isoﬂurane exerts a
concentration-dependent effect to reduce and slow the rates of state 3respiration and NADH oxidation, to further expand state 2 and contract
state 3matrix volume, and to partially depress states 2 and 3ΔΨm.More-
over, isoﬂurane concentration-dependently increases state 2 [Ca2+]m
resulting from added CaCl2 with NaPM, but not with KPM, substrate.
The isoﬂurane-induced increases in state 2 [Ca2+]mwithNaPMsubstrate,
despite increasingly lower ΔΨm and higher matrix volume, indicate that
the apparent rise in Ca2+ inﬂux, or decline in Ca2+ efﬂux, across the
inner mitochondrial membrane (IMM) is more dependent on altered
Ca2+ binding afﬁnities of the two principal Ca2+ transporters CU and
NCE, and less dependent on electrochemical gradient of Ca2+ across
the (IMM) at increasing isoﬂurane concentrations. Isoﬂurane is a very
lipid soluble compound that can modify protein structure. The use of
KPM as substrate and an NCE inhibitor demonstrates that isoﬂurane's ef-
fect to increase [Ca2+]m is totally blocked, which strongly suggests that
isoﬂurane decreases the net efﬂux of Ca2+ by directly or allosterically at-
tenuating NCE activity. Our bioenergetic experiments support the notion
that isoﬂurane also inhibits complex I to decrease the rate and prolong
the duration of state 3 electron transfer and ADP phosphorylation, de-
spite the lower ΔΨm which would tend to enhance respiration.
In the context of cardioprotection, the isoﬂurane-mediated atten-
uation of NCE activity leading to reduced net Ca2+ efﬂux (i.e. in-
creased [Ca2+]m) could be an initiating factor in the sequence of
events leading to protection against IR injury. On the other hand, iso-
ﬂurane may mediate cardioprotection in large part by depressing mi-
tochondrial bioenergetics before, during, or after IR injury. It is not
clear from this study if isoﬂurane's effects to enhance [Ca2+]m
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460 B. Agarwal et al. / Biochimica et Biophysica Acta 1817 (2012) 453–465while depressing mitochondrial NCE activity and bioenergetics sin-
gularly or together mediate cardioprotection. What appears evident
from the data is that isoﬂurane's effect to enhance [Ca2+]m exacer-
bates the depression of the bioenergetic state by its inﬂuence to re-
duce ΔΨm.
4.1. Isoﬂurane depresses mitochondrial bioenergetics —implications for
cardioprotection
Altered mitochondrial function with APC or APOC has largely been
characterized by monitoring changes in NADH levels or transporter/
enzyme activities (e.g., complex I activity) that link to other effectors
being affected in triggering the protective mechanism against myocar-
dial IR injury. This notion is consistent with the observation of a small
sevoﬂurane-induced increase in NADH level in isolated perfused guinea
pig hearts [26]. In our isolated mitochondrial study, isoﬂurane itself
caused little change in state 2 NADH level, whereas it greatly attenuated
the extent of NADH oxidation during state 3 respiration. This is most
likely due to the slowed rates of electron transfer and ADP phosphory-
lation so that the slower rate of H+ pumping by NADH-linked interme-
diates is bettermatched to the slower rate of H+ entering thematrix via
complex V (F1F0-ATPase). This would prolong the duration of state 3
ADP phosphorylation, which is consistently reﬂected in the measured
durations of state 3 NADH oxidation, respiration, ΔΨm, andmatrix con-
traction with complex I substrates (NaPM or KPM).Previous studies in isolated perfused hearts show that volatile an-
esthetics attenuate electron transport chain (ETC) activity at the level
of complex I based on decreased NADH oxidation. This in turn is
thought to stimulate a small amount of ROS production and/or activa-
tion of mitochondrial ATP-sensitive potassium channels (mKATP) and
mitochondrial calcium-sensitive potassium channels (mKCa) as effec-
tors in cardioprotection induced by anesthetics or other compounds
[27,28]. Moreover, inhibition of complex I has been suggested as a
likely target of volatile anesthetics in isolated cardiac mitochondria
[29–31] and in other experimental models [32–34]. Our results on
isoﬂurane-induced decreases in state 3 NADH oxidation and respira-
tion, and the accentuated fall in state 3 ΔΨm, indicate attenuation of
electron transfer and H+ pumping by ETC, especially at complex I.
This notion is substantiated by the measured time-courses of matrix
pH with BCECF-AM dye that showed no change in matrix pH at differ-
ent concentrations of isoﬂurane compared to the control and DMSO
groups (data not shown). This appears to rule out the possibility
that isoﬂurane has a protonophoric effect to allow H+ leak through
the IMM [35], which would itself enhance the respiratory rate, but
which is the opposite of what was observed.
To substantiate our view that isoﬂurane decreases state 3 electron
transfer and ADP phosphorylation by inhibiting complex I, we con-
ducted bioenergetic experiments with both complex I substrate
(NaPM) and complex II substrate (NaSuc) with 0.5 mM added CaCl2
or no added CaCl2 (Fig. 4A–D). Speciﬁcally, we compared the change
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inhibitor rotenone and found that 1 mM isoﬂurane mimicked inhi-
bition of complex I equivalent to 30 nM rotenone. These results
demonstrate similar effects of isoﬂurane (1 mM) and rotenone
(30 nM) using different substrates and at different [Ca2+]e and
([Ca2+]m.
Taken together, the available data support our observations that
isoﬂurane reduces mitochondrial bioenergetic activity by decreas-
ing NADH oxidation and ADP phosphorylation. In turn, this may
ultimately preserve the mitochondrial redox state needed for ef-
fective mitochondrial ATP production during reperfusion [26].
The strategy of targeting ETC complexes to modify electron trans-
fer [34], and in part ROS production from ETC complexes [1,36],
can also provide an alternative strategy for cardioprotection by
isoﬂurane.
Although not probed in this study, the possibility of a moderate in-
crease in ROS production while attenuating complex I activity cannot
be excluded, as isoﬂurane is shown here to moderately reduce O2
consumption in isolated mitochondria. Prior studies suggest a dual ef-
fect of isoﬂurane on the ETC: mild uncoupling combined with attenu-
ated complex I activity [34,37], and further effects on complexes
downstream of complex I, predominantly, complex III [38]; the latterwas suggested to trigger ROS production as a mechanism of
isoﬂurane-induced cardioprotection [4,36]. A high NADH/NAD+
ratio in the matrix is favorable to induce an increase in electron leak
and ROS production if electrons are blocked in the FeS clusters of
the FMN complex as a result of reduced NADH pool [39–41]. The
small decrease in ΔΨm induced by isoﬂurane implies that this may
be a direct or indirect factor in anesthetic-mediated cardioprotection
[11,12], at least in part by inhibiting the ROS production that can
occur in a highly reduced state [20,42]. Attenuation of mitochondrial
respiration with isoﬂurane by inhibiting complex I may exert cardio-
protection [37,43] by attenuating both ΔΨm and ROS production
[12,44]. Thus, if isoﬂurane preserves the NADH pool by attenuating
complex I activity and stimulating NADH-induced ROS production,
then this could be an important trigger of cardioprotective pathways
that lead to protection against IR injury [45]. These direct effects may
contribute to the overall signaling cascade involved in APC and other
anesthetic-mediated cardioprotective strategies in which mitochon-
drial ROS has been implicated as the critical trigger [8,46]. Indeed, mi-
tochondrial ROS generation is inﬂuenced by [Ca2+]m, ΔΨm, and redox
state [1], and knowledge of how isoﬂurane directly modulates mito-
chondrial function should provide novel insights into the mecha-
nisms of anesthetic-mediated cardioprotection [4].
Iso CaCl2NaPM
A
y = 0.234x + 0.708 
R2 = 0.9928
0.5
0.7
0.9
1.1
1.3
Isoflurane Concentration (mM)
M
at
ri
x 
Fr
ee
 [
C
a2
+ ]
 In
cr
ea
se
 w
it
h 
C
a2
+  
(µ
M
)
B
C D
0 0.5 1 1.5 2
0
0.25
0.5
0.75
1
1.25
1.5
0 120 240 360 480 600 720 840
Time (s)
DMSO (KPM)
Iso=1.0mM (KPM)
DMSO (CGP+NaPM)
Iso=1.0mM (CGP+NaPM)
KPM/NaPM
DMSO/Iso
CaCl2
RR
NaCl
±CGP
0
0.25
0.5
0.75
1
1.25
1.5
450 (s) 600 (s) 900 (s)
 Time (s)
M
at
ri
x 
F
re
e 
[C
a2
+ ]
,µ
M
M
at
ri
x 
F
re
e 
[C
a2
+ ]
,µ
M
DMSO (KPM)
Iso=1.0mM (KPM)
Fig. 7. (A) Time-course of mitochondrial free Ca2+ ([Ca2+]m) with 0.5 mM added CaCl2 (≈200 nM free Ca2+) during state 2 respiration with Na+-pyruvate/malate (NaPM) and
isoﬂurane (0.5, 1, 1.5 and 2 mM) compared to control (no treatment) and vehicle (DMSO) groups. (B) Summary of the effects of adding CaCl2 on [Ca2+]m during state 2 respiration
with NaPM. Note that isoﬂurane had no effect on altering basal [Ca2+]m but that [Ca2+]m was markedly elevated after adding CaCl2. Moreover, isoﬂurane stepwise increased state 2
[Ca2+]m, compared to DMSO (Iso=0 mM), suggesting a net increase in Ca2+ uptake. (C) Time-course of [Ca2+]m with 0.5 mM added CaCl2 (≈200 nM free Ca2+) and RR+10 mM
added NaCl during state 2 respiration with substrates NaPM+CGP or KPM and isoﬂurane (1 mM) compared to DMSO. (D) Summary effect of adding CaCl2 and RR+NaCl on [Ca2+]m
during state 2 respirationwith KPM.Note that isoﬂurane did not induce any further increase in [Ca2+]m, compared toDMSO, after adding CaCl2with either substrates; however, isoﬂurane
attenuatedmatrix Ca2+ efﬂux, as assessed bydecreased [Ca2+]mwithNaCl addition after blocking the CUwith RRwhenusing KPM substrate, indicating isoﬂurane-induced attenuation of
NCE activity. Traces represent means of 4 replicates in each group and summary data are plotted as means±SE of 4 replicates. * indicates signiﬁcant differences exist between isoﬂurane
and control/DMSO groups, whereas # indicates signiﬁcant differences exist between high and low isoﬂurane groups (pb0.05).
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decrease in membrane potential (ΔΨm) and increase in matrix volume
Our study shows that isoﬂurane causes a slight concentration-
dependent decrease in ΔΨm during state 2 respiration (Fig. 5). This
indicates that the observed increase in state 2 [Ca2+]m with increas-
ing isoﬂurane concentration in the NaPM substrate experiments
(Fig. 7A, B) is not solely dependent on ΔΨm for the electrochemical
gradient to promote enhanced Ca2+ inﬂux into the matrix via the
CU. In general, Ca2+ uptake via the CU occurs at the expense of
ΔΨm, i.e., it utilizes the energy of ΔΨm to transport extra-matrix
free Ca2+ across the IMM [3,47]. This is consistent with our previous
study that showed a CaCl2 concentration-dependent increase in Ca2+
uptake, through the ruthenium red-sensitive CU, in freshly isolated
cardiac mitochondria at a high ΔΨm [18]. Thus, one would expect
that a decrease in Ca2+ uptake would occur when ΔΨm is decreased,
contrary to what we observed in this study, indicating other possible
mechanisms associated with this increase in state 2 [Ca2+]m.
To further conﬁrm that isoﬂurane increases state 2 [Ca2+]m with
NaPM substrate and is independent of ΔΨm, we added 0.5 mM CaCl2
and measured [Ca2+]m in the presence of an uncoupler, dinitrophenol
(DNP; 20 μM), and then added DMSO or 1 mM isoﬂurane. This data
showed that DNP, which induced partialΔΨm depolarization decreased[Ca2+]m; in contrast, isoﬂurane in the presence of DNP increased [Ca2+]m
despite partial ΔΨm depolarization (data not shown).
Since isoﬂurane and CaCl2 both led to matrix volume expansion
during state 2 respiration (Fig. 6), the increase in state 2 [Ca2+]m
that we observed with increasing isoﬂurane concentration in the
NaPM substrate experiments (Fig. 7A, B) may be somewhat underes-
timated due to apparent decrease in indo-1 AM ﬂuorescence by light
scattering. This indicates that the increase in state 2 [Ca2+]m is not
due to matrix volume contraction.
We examined other possibilities for increased state 2 [Ca2+]m
with isoﬂurane using NaPM as substrate. For example, there could
occur in an apparent increase in indo-1 AM ﬂuorescence via an
indo-1 and isoﬂurane interaction, via matrix Ca2+ buffering proteins,
and/or from decreased matrix pH via a possible protonophoric effect
of isoﬂurane. To test these possibilities, experiments were conducted
in triton-x treated indo-1 AM loaded mitochondria and BCECF-AM
loadedmitochondria in the presence of DMSO and isoﬂurane. Because
we found no change in indo-1 AM ﬂuorescence as well as no change
in matrix pH at different concentrations of isoﬂurane compared to
the control and DMSO groups (data not shown), this ruled out these
possibilities. Also, with the minimal effect of isoﬂurane on state 2
ΔΨm depolarization (2.7%), we would not expect substantial change
in pH as proton pumps must be working fast to maintain the same
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of very little change in state 2 respiration at different isoﬂurane con-
centrations (Fig. 2A).
We also examined [Ca2+]m dynamics after adding CaCl2 using the
CU inhibitor RR, which was added before adding NaPM. This data (not
displayed) did not demonstrate any increase in [Ca2+]m in control
(DMSO) or in isoﬂurane-treated mitochondria, thus excluding anoth-
er mechanism, i.e. isoﬂurane-induced alteration of indo-1 ﬂuores-
cence, as a cause for the increased [Ca2+]m in the presence of
isoﬂurane.
Another possibility for increased state 2 [Ca2+]m with NaPM sub-
strate could arise from an effect of isoﬂurane to reduce matrix Ca2+
buffering by Ca2+ binding proteins. It is conceivable that isoﬂurane
may intercalate into the IMM and block Ca2+ binding proteins (e.g.,
annexin) to interact with the phospholipid bilayer through phosphor-
ylation [48,49]. Though, we can not dismiss this possibility, when iso-
ﬂurane was added after CaCl2 in selected control and DMSO
experiments we did not see any further increase in [Ca2+]m (data
not shown). It is also unlikely that isoﬂurane might affect matrix
Ca2+-phosphate precipitate formation because the solubility product
constants for CaHPO4 and Ca3(PO4)2 formation are Ksp=10−7 and
3∗10−30, respectively. With a matrix pH of around 7.2–7.3 and the
above Ksp values, [Ca2+]m would need to exceed 2 μM for any appre-
ciable amount of Ca2+-phosphate formation [50,51].
From all the possibilities, we ﬁrst concluded that the increases in
state 2 [Ca2+]m with increasing isoﬂurane concentration in the
NaPM substrate experiments (Fig. 7A, B) were most likely due to in-
creased inﬂux or decreased efﬂux of Ca2+ across the IMM that in-
volves direct or allosteric activation of either the CU or inhibition of
the NCE by isoﬂurane. Because of isoﬂurane's high lipophilicity, it
can directly or indirectly (allosterically) interact with the lipids
around the Ca2+ transporters or with their hydrophobic peptides to
alter their binding afﬁnities of Ca2+. For example, we thought that
isoﬂurane might decrease the Km of Ca2+ for the CU and/or increase
the Vmax of the CU to increase binding of Ca2+ to the CU and/or en-
hance maximal activity of the CU to promote enhanced Ca2+m up-
take. Indeed, it was reported that isoﬂurane activates mKATP
channels reconstituted in lipid bilayers [52] and that the mKATP chan-
nel blocker, 5-hydroxydecanoate (5-HD), attenuates the cardiopro-
tective effects of isoﬂurane in an isolated perfused rabbit heart
model [53]. In preliminary experiments we found that the mKCa chan-
nel inhibitor paxilline had no effect on the isoﬂurane-mediated rise in
[Ca2+]m (data not shown).
To distinguish if isoﬂurane acts on the CU and/or the NCE to in-
crease [Ca2+]m after adding CaCl2 using the substrate NaPM, we
also measured [Ca2+]m using substrate PMK, or NaPM in the presence
of NCE inhibitor CGP-37157, with an extended time-line protocol
(Fig. 1C). After energizing mitochondria with KPM or NaPM+CGP,
the CU inhibitor RR and then NaCl were added in the presence of
DMSO or 1 mM isoﬂurane (Fig. 7C, D). In this protocol, isoﬂurane,
like DMSO, did not induce any further increase in [Ca2+]m after add-
ing CaCl2; moreover, NaCl had no effect to activate Ca2+ efﬂux as
shown by no further change in [Ca2+]m when using NaPM+CGP.
When using KPM, and after blocking the CU with RR, isoﬂurane atten-
uated the fall in [Ca2+]m, i.e., decreased Ca2+m efﬂux, after adding
NaCl to activate NCE. These data showed clearly that the isoﬂurane-
enhanced, CaCl2 induced, increase in state 2 [Ca2+]m with Na+-con-
taining substrate NaPM occurs primarily by attenuating the activity
of the NCE. The mechanism how isoﬂurane attenuates NCE activity
(direct or indirect; change in protein conﬁguration; post-
translational modiﬁcation) is not known at this time. However, this
is the ﬁrst report demonstrating that a volatile anesthetic can attenu-
ate matrix Ca2+ efﬂux, and explains in part why we observed an in-
creased [Ca2+]m despite a decrease in ΔΨm.
To provide additional evidence that the isoﬂurane-induced in-
crease in state 2 [Ca2+]m with NaPM as substrate results frominhibited NCE activity, we monitored [Ca2+]e under the extended
time-line protocol (Fig. 1C) to examine NCE kinetics under the condi-
tions of reduced buffer EGTA (40 μM) and added CaCl2 (30 μM) to
elicit [Ca2+]e responses comparable to the presented studies. With-
out the extensive buffering of Ca2+ in the extra-matrix buffer, we
could observe changes in [Ca2+]e as Ca2+enters or exits the matrix.
We found that isoﬂurane did not alter the gradual fall in [Ca2+]e
due to uptake via CU after the fast initial rise due to adding CaCl2
but did attenuate the gradual rise in [Ca2+]e after adding RR and
then NaCl to stimulate NCE (data not shown).
4.3. Implication of isoﬂurane-induced increased [Ca2+]m to bioenergetics
[Ca2+]m is believed to enhance/stimulate mitochondrial dehydro-
genase enzymes, TCA cycle, and NADH production, and hence to in-
crease state 3 respiration rate. Thus, it could be expected that the
CaCl2-induced enhancement of [Ca2+]m by isoﬂurane would enhance
respiration and NADH, which it did not (Figs. 2–4). This discrepancy
may be attributed to several factors. First, 10 mM of substrate
(NaPM or KPM) to energize mitochondria may saturate the ADP-
independent TCA cycle ﬂux. In a recent study [54], it was reported
that to observe an effect of increased Ca2+ to stimulate state 3
NADH production and respiration, a low substrate concentration is
necessary. Second, the substrate glutamate+malate provides a great-
er NADH response to increasing extra-matrix [Ca2+]. Third, state 2
[Ca2+]m after adding CaCl2 in our study is about 700 nM with DMSO
and rises to over 1000 nM after adding isoﬂurane (Fig. 7A, C), which
may be high enough to saturate the mitochondrial dehydrogenase
enzymes [55], and hence the TCA cycle ﬂux that produce NADH for
the ETC and OxPhos. Fourth, isoﬂurane has another effect to attenuate
complex I activity, which itself leads to decreased electron ﬂow and
ADP phosphorylation during state 3 respiration. Therefore, the in-
creased state 2 [Ca2+]m that we observe with isoﬂurane with saturat-
ing NaPM substrate concentration (10 mM) would not be expected to
increase state 3 respiration and NADH oxidation. However, when we
used 10 mM NaSuc as the substrate we found that the duration of
state 3 NADH oxidation was shorter (faster respiration) after adding
1 mM isoﬂurane with or without added CaCl2 (Fig. 4A–D).
4.4. Implication of isoﬂurane-induced increased [Ca2+]m to cardioprotection
One might expect that a decrease in mitochondrial Ca2+ uptake
would occur when ΔΨm is decreased. Interestingly, in our study, a de-
cline in state 2 ΔΨm in the presence of isoﬂurane was associated with
a greater accumulation of Ca2+ in the matrix with NaPM substrate.
This suggests that isoﬂurane's cardioprotective effect is a result of
an indirect interplay between a mild decrease in ΔΨm due to slower
respiration and an enhanced net Ca2+ uptake, which tends to further
reduce ΔΨm. This notion is supported by our mitochondrial Ca2+ up-
take measurement in the presence of an uncoupler (DNP; 20 μM) and
in the presence of DMSO and isoﬂurane (1 mM), since DNP was sug-
gested to be cardioprotective [12]. Thus, a partial decrease in ΔΨm by
isoﬂurane during ischemia could preserve the H+ gradient necessary
for efﬁcient ATP synthesis to meet the energy demand of cardiomyo-
cytes during reperfusion to reduce IR injury.
Previous studies of volatile anesthetic-preconditioning of isolated
cardiomyocytes [11,12,56] and isolated perfused hearts [57] demon-
strate this therapy attenuates Ca2+m overload. In this case the protec-
tive effects are measured after washout of the volatile anesthetic that
characterizes the memory phase of preconditioning. In contrast, we
focused here on the direct effects of a volatile anesthetic on mitochon-
drial bioenergetics and Ca2+ handling, which showed an increase in
state 2 [Ca2+]m in the presence of isoﬂurane with NaPM as substrate
due to an attenuation of the NCE activity. This anesthetic-induced in-
crease in [Ca2+]m we observed may be part of a triggering mechanism
to initiate signaling pathways for preconditioning that may translate
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and/or CU activity.
A recent study in isolated cardiomyocytes [12] showed that APC
affords protection against oxidative stress by attenuating ΔΨm that
leads to decreased ROS generation and attenuation of Ca2+m accumu-
lation; in contrast, in the present study in isolated cardiac mitochon-
dria, a similar decrease in ΔΨm resulted in an increase in [Ca2+]m. The
mechanism for an APC-mediated decrease in ΔΨm is not clear. A large
increase in [Ca2+]m is known to be deleterious as it leads to mPTP
opening during cardiac IR injury; paradoxically our study implies
that the small increases in [Ca2+]m elicited by isoﬂurane could play
a signiﬁcant role in volatile anesthetic-mediated cardioprotection by
reducing electron ﬂow and proton pumping, and thereby reducing
state 3 respiration, NADH oxidation, ADP phosphorylation, and ΔΨm.
Our ﬁnding that exposure of mitochondria to isoﬂurane showed
enhanced [Ca2+]m may seem to be anti-protective. Although Ca2+
overload initiates mPTP opening [58], the enhanced Ca2+ uptake
with isoﬂurane did not induce mPTP opening in this study as ob-
served by the return of the measured indices to state 4. However, iso-
ﬂurane, by depressing the bioenergetic state of mitochondria with the
assistance of a small increase in Ca2+ uptake, may activate signaling
pathways that reduce Ca2+ overload on reperfusion after ischemia
[57] and reduce activation of mPTP [57,59]. Permanent opening of
the mPTP is thought to be induced or exacerbated by excess ROS
emission [60] and/or excess Ca2+ loading. Opening of the mKATP
channel maymodify ΔΨm [61] or matrix volume and pH [24,62] to re-
duce the deleterious Ca2+ overload.
Taking together, the mechanism(s) of cardiac protection afforded
by volatile anesthetics involves the interplay of [Ca2+]m regulation,
bioenergetic control, and possibly ROS emission. Our study suggests
that amoderate increase in [Ca2+]m coupled to depressedmitochondrial
bioenergetics may together be important factors in the triggering phase
of volatile anesthetic-mediated pre- and post-conditioning, or in cardio-
protection in general.
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